Marijuana to Schedule III: What Changes, What Doesn’t, and What Comes Next
Federal Hemp Ban Explained: A State-by-State Analysis & 2026 Outlook with Vicente LLP
Multijurisdictional Employers, Part 4: Marijuana and Other Drug Testing in the Workplace
Weed in the Workplace: What’s the Tea in L&E?
Cannabis Law Now Podcast - From Law Firm to Board Room: The Journey of a Cannabis Entrepreneur
The Impact of the Horn Case on RICO - RICO Report Podcast
Cannabis Law Now Podcast: Cannabis and Hemp Federal and State Advocacy in 2025
Cannabis Law Now Podcast: New York Cannabis: Ups, Downs, and In Between
Cannabis Law Now Podcast: Local Government and Cannabis Enforcement — What Matters and Why
12 Days of Regulatory Insights: Day 5 - Cannabis Chronicles — Regulatory Oversight Podcast
Florida Medical Cannabis Business Licensing Process: What Happens Next for MMTC Applicants?
Bringing Your Cannabis Brand to New York
Cannabis Law Now Podcast: Building a Lasting Cannabis Brand with Tiffany Chin from Death Row Cannabis
Cannabis & Psychedelics On the 2024 Ballot
Cannabis Rescheduling: Timeline, Tax Strategies & 280E
Cannabis Law Now Podcast: 2024 Cannabis Industry Pitfalls on Blast
Mitigating and Addressing Litigation Risks for Cannabis Businesses
Cannabis M&A: Pain Points and Opportunities
Managing Labor and Employment Complexities in Cannabis Businesses
Work This Way: A Labor & Employment Law Podcast - Episode 29: Weed in the Workplace with Christy Rogers of Maynard Nexsen
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have news from Florida on their ballot initiative. We check in on Oklahoma, where the governor speaks...more
President Trump recently signed Executive Order “Increasing Medical Marijuana and Cannabidiol Research,” published on December 18, 2025. This important measure directed federal agencies to reclassify cannabis from Schedule 1...more
Maine has amended its cannabis excise tax law to offer tax relief for some cannabis businesses. The new law, which took effect on January 11, 2026, creates specific exemptions from excise tax for certain transfers of...more
This issue of McDermott’s Healthcare Regulatory Check-Up highlights regulatory activity from December 2025. The end of the year brought a significant number of newly proposed Centers for Medicare & Medicaid Services (CMS)...more
Predator Death Penalty Act - This week, the House passed the Child Predator Death Penalty Act, sponsored by Matt Simpson. This legislation would make the first‑degree rape, sodomy, or sexual torture of a child under 12 a...more
On December 18, 2025, President Trump signed an Executive Order (the “EO”) directing the Department of Justice (DOJ) to complete the rulemaking process related to rescheduling marijuana to Schedule III and committing to...more
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, the House began consideration of a bill to regulate hemp-derived CBD. In Florida, there’s controversy over...more
Though it has been around for nearly a decade, the Pennsylvania Medical Marijuana Act continues to cause considerable confusion for employers. A recent decision helps to provide some guidance to employers about how the law...more
Countless businesses, including tribal nations operating through compact agreements with the state of Minnesota, anticipate entering the North Star State’s legal cannabis market in 2026. Since the state legalized adult-use...more
On January 13, 2026, the Virginia House of Delegates prefiled House Bill 642 (HB 642), which establishes a proposed framework for the creation of a regulated commercial adult-use marijuana market in the Commonwealth. Changes...more
Federal cannabis policy is entering 2026 in a “split-screen” posture: marijuana appears to be moving toward a less restrictive federal status, while hemp is facing a major federal contraction (covered in our next installment,...more
President Trump’s December 2025 Executive Order signals a possible shift in federal marijuana policy, but many employers still have a lawful and legitimate basis to prohibit impairment at work. Employers that test for...more
Employers are facing one of the most consequential shifts on workplace drug policy in recent memory. On December 18, 2025, President Trump signed an Executive Order that reclassifies marijuana from a Schedule I to a Schedule...more
Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry. In this edition of the buzz,...more
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, lawmakers considered blocking the administration’s move to reschedule cannabis. Virginia began the move to...more
Federal cannabis policy is entering a new phase. The Trump administration’s executive order to reclassify marijuana under the Controlled Substances Act (CSA) marks a historic shift with broad implications for compliance,...more
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we see yet another attempt to legalize adult-use cannabis in New Hampshire. A new federal funding bill...more
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal, and regulatory landscape. Release of the 2025–2030 Dietary Guidelines for Americans. On January 7, the...more
The recent federal policy shift, marked by Executive Order 14370: Increasing Medical Marijuana and Cannabidiol Research, reflects not only a legal development but also a broader cultural transformation....more
As we reflect on the whirlwind that was 2025, we find ourselves cautiously optimistic about the path ahead for the cannabis industry. While the year brought both unprecedented federal action and intensifying challenges, we...more
Newly released year-end reports from the New York Office of Cannabis Management (OCM), highlighted by CannabisWire, show a clear shift in the state’s cannabis enforcement landscape....more
On December 18, 2025, President Donald Trump signed an executive order that may breathe new life into efforts to move marijuana to a less restrictive schedule under the Controlled Substances Act (“CSA”)....more
On the heels of an executive order1 that is intended to reschedule medical marijuana and increase federal cannabidiol research, the Centers for Medicare & Medicaid Services (CMS) Innovation Center recently announced hemp...more
Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: • AGs Drive Home $150M Deal With Mercedes Over Diesel...more
The legal landscape for workplace drug testing is likely to see some significant changes in 2026. This article summarizes the shifts in federal and state policy, continuing and emerging challenges for employers, and what...more